EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oligoethylene Phosphoramidate‐Based Kinase Inhibitor Prodrugs – Solubility, Enzyme Inhibition, and Hydrolysis

Sarah Spiewok, Maximilian Schaefer, Markus Lamla, Yannick Jaritz, Alexander J C Kuehne iD

Chemistry – A European Journal · 2025

DOI: 10.1002/chem.202404618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Sarah Spiewok und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic and Macromolecular Chemistry, Ulm University, Albert-Einstein-Allee 11, 89081, Ulm, Germany. Hauptthemen laut MEDLINE: Prodrugs, Protein Kinase Inhibitors, Amides, Phosphoric Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficiency of kinase inhibiting cancer therapeutics is often limited by their poor solubility in water. PEGylation is one possible strategy to improve the solubility of the drug, however, means to cleave off the PEG after reaching the target is important to make use of the therapeutic effects of the native drug. Moreover, the length of the PEG chains will have an effect on the solubility and binding. In this study, we want to extend our understanding of solubilizing oligo ethylene glycol (OEG) chains connected to kinase inhibitors using a pH labile phosphoramidate linker. We synthesize a library of drug‐OEG conjugates for Ceritinib, Crizotinib, Palbociclib, and Ribocilib kinase inhibitors with n=2, 3, 4 and 8 OEG repeat units. We study the influence on water solubility, enzyme inhibition, and pH induced hydrolysis. A maximum in solubility is obtained for n=3 or 4. We show that small differences in chain length can strongly influence the water solubility, while all other properties remain relatively comparable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsProtein Kinase InhibitorsAmidesPhosphoric AcidsPolyethylene GlycolsSolubilityHydrolysisHydrogen-Ion ConcentrationPyridinesPyrimidinesWaterHumansSulfones

Stichwörter der Autor:innen

Drug functionalizationPEG-drug conjugatesWater solubilitypH trigger

Substanzen

ProdrugsProtein Kinase InhibitorsAmidesPhosphoric Acidsphosphoramidic acidPyridinesPolyethylene GlycolsPyrimidinesceritinibWater

Autor:innen und Institutionen

  • Institute of Organic and Macromolecular Chemistry, Ulm University, Albert-Einstein-Allee 11, 89081, Ulm, Germany.

ORCID-Profile: Alexander J C Kuehne

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Spiewok, S., Schaefer, M., Lamla, M., Jaritz, Y., & Kuehne, A. J. C. (2025). Oligoethylene Phosphoramidate‐Based Kinase Inhibitor Prodrugs – Solubility, Enzyme Inhibition, and Hydrolysis. Chemistry – A European Journal. https://doi.org/10.1002/chem.202404618

Vancouver

Spiewok S, Schaefer M, Lamla M, Jaritz Y, Kuehne AJC. Oligoethylene Phosphoramidate‐Based Kinase Inhibitor Prodrugs – Solubility, Enzyme Inhibition, and Hydrolysis. Chemistry – A European Journal. 2025. doi:10.1002/chem.202404618

BibTeX
@article{Spiewok2025,
  author = {Spiewok, Sarah and Schaefer, Maximilian and Lamla, Markus and Jaritz, Yannick and Kuehne, Alexander J C},
  title = {Oligoethylene Phosphoramidate‐Based Kinase Inhibitor Prodrugs – Solubility, Enzyme Inhibition, and Hydrolysis},
  journal = {Chemistry – A European Journal},
  year = {2025},
  doi = {10.1002/chem.202404618}
}
Kostenlos starten →